{"id":645459,"date":"2017-07-20T04:05:42","date_gmt":"2017-07-20T04:05:42","guid":{"rendered":"https:\/\/enterpriseam.com\/egypt\/2017\/07\/20\/efsa-approves-fair-value-report-on-dbk-pharma-ahead-of-ipo\/"},"modified":"2017-07-20T04:05:42","modified_gmt":"2017-07-20T04:05:42","slug":"efsa-approves-fair-value-report-on-dbk-pharma-ahead-of-ipo","status":"publish","type":"post","link":"https:\/\/enterpriseam.com\/egypt\/2017\/07\/20\/efsa-approves-fair-value-report-on-dbk-pharma-ahead-of-ipo\/","title":{"rendered":"EFSA approves fair value report on DBK Pharma ahead of IPO"},"content":{"rendered":"

<\/a> IPO WATCH-<\/strong> The Egyptian Financial Supervisory Authority (EFSA) signed off yesterday on DBK Pharma\u2019s fair value assessment of EGP 3.1 per share ahead of the company's planned initial public offering of 35% of its shares, sources close to the matter tell Al Borsa<\/a>. The report was prepared by financial consultancy firm FinCorp. We had last noted in May<\/a> that DBK Pharma\u2019s second attempt to list on the EGX had been running into roadblocks. DBK\u2019s first attempt to IPO in 2015 had also failed when the company was unable to raise enough to cover its offering.<\/p>\n","protected":false},"excerpt":{"rendered":"

IPO WATCH- The Egyptian Financial Supervisory Authority (EFSA) signed off yesterday on DBK Pharma\u2019s fair value assessment of EGP 3.1 per share ahead of the company's planned initial public offering of 35% of its shares, sources close to the matter tell Al Borsa. The report was prepared by financial consultancy firm FinCorp. We had last […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"single-feature.php","format":"standard","meta":{"_acf_changed":false,"newspack_ads_suppress_ads":false,"newspack_popups_has_disabled_popups":false,"newspack_sponsor_sponsorship_scope":"","newspack_sponsor_native_byline_display":"inherit","newspack_sponsor_native_category_display":"inherit","newspack_sponsor_underwriter_style":"inherit","newspack_sponsor_underwriter_placement":"inherit","ep_exclude_from_search":false,"_primary_brand":0,"newspack_featured_image_position":"","newspack_post_subtitle":"","newspack_article_summary_title":"Overview:","newspack_article_summary":"","newspack_hide_updated_date":false,"newspack_show_updated_date":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[8572],"tags":[72,2380],"brand":[],"newspack_spnsrs_tax":[],"class_list":["post-645459","post","type-post","status-publish","format-standard","hentry","category-speed-round","tag-enterpriseam","tag-speed-round","wpautop","entry"],"acf":{"mongo_id":"676fec79-ac2c-4d6b-8fb9-9d53d8bb24e7","order":"0","is_powered_by":true,"section_story_id":"edfe9036-f4ac-4fc6-aba2-01dc4933b987","story_type":"1","photo_url":"","photo_position":"above","related_issue":[645451],"teaser":"","voice_url":""},"yoast_head":"\nEFSA approves fair value report on DBK Pharma ahead of IPO - EnterpriseAM Egypt<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/enterpriseam.com\/egypt\/2017\/07\/20\/efsa-approves-fair-value-report-on-dbk-pharma-ahead-of-ipo\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EFSA approves fair value report on DBK Pharma ahead of IPO\" \/>\n<meta property=\"og:description\" content=\"IPO WATCH- The Egyptian Financial Supervisory Authority (EFSA) signed off yesterday on DBK Pharma\u2019s fair value assessment of EGP 3.1 per share ahead of the company's planned initial public offering of 35% of its shares, sources close to the matter tell Al Borsa. The report was prepared by financial consultancy firm FinCorp. We had last […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/enterpriseam.com\/egypt\/2017\/07\/20\/efsa-approves-fair-value-report-on-dbk-pharma-ahead-of-ipo\/\" \/>\n<meta property=\"og:site_name\" content=\"EnterpriseAM Egypt\" \/>\n<meta property=\"article:published_time\" content=\"2017-07-20T04:05:42+00:00\" \/>\n<meta name=\"author\" content=\"enterpriseam admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"enterpriseam admin\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/07\/20\/efsa-approves-fair-value-report-on-dbk-pharma-ahead-of-ipo\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/07\/20\/efsa-approves-fair-value-report-on-dbk-pharma-ahead-of-ipo\/\"},\"author\":{\"name\":\"enterpriseam admin\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\"},\"headline\":\"EFSA approves fair value report on DBK Pharma ahead of IPO\",\"datePublished\":\"2017-07-20T04:05:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/07\/20\/efsa-approves-fair-value-report-on-dbk-pharma-ahead-of-ipo\/\"},\"wordCount\":107,\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\"},\"keywords\":[\"EnterpriseAM\",\"SPEED ROUND\"],\"articleSection\":[\"Speed Round\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/07\/20\/efsa-approves-fair-value-report-on-dbk-pharma-ahead-of-ipo\/\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/2017\/07\/20\/efsa-approves-fair-value-report-on-dbk-pharma-ahead-of-ipo\/\",\"name\":\"EFSA approves fair value report on DBK Pharma ahead of IPO - EnterpriseAM Egypt\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#website\"},\"datePublished\":\"2017-07-20T04:05:42+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/07\/20\/efsa-approves-fair-value-report-on-dbk-pharma-ahead-of-ipo\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/enterpriseam.com\/egypt\/2017\/07\/20\/efsa-approves-fair-value-report-on-dbk-pharma-ahead-of-ipo\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/07\/20\/efsa-approves-fair-value-report-on-dbk-pharma-ahead-of-ipo\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/enterpriseam.com\/egypt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EFSA approves fair value report on DBK Pharma ahead of IPO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#website\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/\",\"name\":\"EnterpriseAM\",\"description\":\"The State of the Nation\",\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/enterpriseam.com\/egypt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\",\"name\":\"EnterpriseAM\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ent.news\/internal\/240894.svg\",\"contentUrl\":\"https:\/\/ent.news\/internal\/240894.svg\",\"caption\":\"EnterpriseAM\"},\"image\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\",\"name\":\"enterpriseam admin\",\"sameAs\":[\"http:\/\/enterpriseam.testing.projectsarea.com\"],\"url\":\"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"EFSA approves fair value report on DBK Pharma ahead of IPO - EnterpriseAM Egypt","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/enterpriseam.com\/egypt\/2017\/07\/20\/efsa-approves-fair-value-report-on-dbk-pharma-ahead-of-ipo\/","og_locale":"en_US","og_type":"article","og_title":"EFSA approves fair value report on DBK Pharma ahead of IPO","og_description":"IPO WATCH- The Egyptian Financial Supervisory Authority (EFSA) signed off yesterday on DBK Pharma\u2019s fair value assessment of EGP 3.1 per share ahead of the company's planned initial public offering of 35% of its shares, sources close to the matter tell Al Borsa. The report was prepared by financial consultancy firm FinCorp. We had last […]","og_url":"https:\/\/enterpriseam.com\/egypt\/2017\/07\/20\/efsa-approves-fair-value-report-on-dbk-pharma-ahead-of-ipo\/","og_site_name":"EnterpriseAM Egypt","article_published_time":"2017-07-20T04:05:42+00:00","author":"enterpriseam admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"enterpriseam admin"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/enterpriseam.com\/egypt\/2017\/07\/20\/efsa-approves-fair-value-report-on-dbk-pharma-ahead-of-ipo\/#article","isPartOf":{"@id":"https:\/\/enterpriseam.com\/egypt\/2017\/07\/20\/efsa-approves-fair-value-report-on-dbk-pharma-ahead-of-ipo\/"},"author":{"name":"enterpriseam admin","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d"},"headline":"EFSA approves fair value report on DBK Pharma ahead of IPO","datePublished":"2017-07-20T04:05:42+00:00","mainEntityOfPage":{"@id":"https:\/\/enterpriseam.com\/egypt\/2017\/07\/20\/efsa-approves-fair-value-report-on-dbk-pharma-ahead-of-ipo\/"},"wordCount":107,"publisher":{"@id":"https:\/\/enterpriseam.com\/egypt\/#organization"},"keywords":["EnterpriseAM","SPEED ROUND"],"articleSection":["Speed Round"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/enterpriseam.com\/egypt\/2017\/07\/20\/efsa-approves-fair-value-report-on-dbk-pharma-ahead-of-ipo\/","url":"https:\/\/enterpriseam.com\/egypt\/2017\/07\/20\/efsa-approves-fair-value-report-on-dbk-pharma-ahead-of-ipo\/","name":"EFSA approves fair value report on DBK Pharma ahead of IPO - EnterpriseAM Egypt","isPartOf":{"@id":"https:\/\/enterpriseam.com\/egypt\/#website"},"datePublished":"2017-07-20T04:05:42+00:00","breadcrumb":{"@id":"https:\/\/enterpriseam.com\/egypt\/2017\/07\/20\/efsa-approves-fair-value-report-on-dbk-pharma-ahead-of-ipo\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/enterpriseam.com\/egypt\/2017\/07\/20\/efsa-approves-fair-value-report-on-dbk-pharma-ahead-of-ipo\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/enterpriseam.com\/egypt\/2017\/07\/20\/efsa-approves-fair-value-report-on-dbk-pharma-ahead-of-ipo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/enterpriseam.com\/egypt\/"},{"@type":"ListItem","position":2,"name":"EFSA approves fair value report on DBK Pharma ahead of IPO"}]},{"@type":"WebSite","@id":"https:\/\/enterpriseam.com\/egypt\/#website","url":"https:\/\/enterpriseam.com\/egypt\/","name":"EnterpriseAM","description":"The State of the Nation","publisher":{"@id":"https:\/\/enterpriseam.com\/egypt\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/enterpriseam.com\/egypt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/enterpriseam.com\/egypt\/#organization","name":"EnterpriseAM","url":"https:\/\/enterpriseam.com\/egypt\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/","url":"https:\/\/ent.news\/internal\/240894.svg","contentUrl":"https:\/\/ent.news\/internal\/240894.svg","caption":"EnterpriseAM"},"image":{"@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d","name":"enterpriseam admin","sameAs":["http:\/\/enterpriseam.testing.projectsarea.com"],"url":"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/"}]}},"featured_image_src":null,"featured_image_src_square":null,"author_info":{"display_name":"enterpriseam admin","author_link":"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/"},"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":648069,"url":"https:\/\/enterpriseam.com\/egypt\/2017\/05\/28\/dbk-pharmas-attempt-at-listing-facing-challenges\/","url_meta":{"origin":645459,"position":0},"title":"DBK Pharma\u2019s attempt at listing facing challenges","author":"enterpriseam admin","date":"28 May 2017","format":false,"excerpt":"IPO WATCH- DBK Pharma\u2019s second attempt to list on the EGX is running into roadblocks, Al Borsa reports. Sources tell the newspaper that the Egyptian Financial Supervisory Authority has not yet approved the company\u2019s fair value assessment. Financial consultancy Fincorp was reportedly working on fair value studies for the listing.","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":641070,"url":"https:\/\/enterpriseam.com\/egypt\/2017\/09\/12\/dbk-pharmas-long-talked-listing-will-take-place-in-4q2017\/","url_meta":{"origin":645459,"position":1},"title":"DBK Pharma\u2019s long-talked listing will take place in 4Q2017","author":"enterpriseam admin","date":"12 September 2017","format":false,"excerpt":"IPO WATCH- DBK Pharma\u2019s drawn out relisting will take place in 4Q2017, the company\u2019s chairman Hamdy El Debeky tells Al Borsa on Monday. The company\u2019s relisting on the EGX had been marred by delays after it was initially expected to take place earlier this year. The Egyptian Financial Supervisory Authority\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":626829,"url":"https:\/\/enterpriseam.com\/egypt\/2018\/07\/12\/exclusive-dbk-pharma-resurrects-ipo-plans-dual-listing-on-egypt-and-saudi-stock-exchanges\/","url_meta":{"origin":645459,"position":2},"title":"EXCLUSIVE- DBK Pharma resurrects IPO, plans dual-listing on Egypt and Saudi stock exchanges","author":"enterpriseam admin","date":"12 July 2018","format":false,"excerpt":"EXCLUSIVE- DBK Pharma resurrects IPO, mulls dual-listing on Egypt and Saudi stock exchanges in 1H2019: DBK Pharma\u2019s long-awaited initial public offering appears to be back on, but this time the company is planning a dual-listing in Egypt and Saudi Arabia, sources close to the transaction told Enterprise yesterday. DBK is\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":647196,"url":"https:\/\/enterpriseam.com\/egypt\/2017\/05\/04\/fincorp-prepares-valuation-studies-ahead-of-three-potential-2017-ipos\/","url_meta":{"origin":645459,"position":3},"title":"Fincorp prepares valuation studies ahead of three potential 2017 IPOs","author":"enterpriseam admin","date":"4 May 2017","format":false,"excerpt":"IPO WATCH- Financial consultancy firm Fincorp is reportedly working on fair value studies for three initial public offerings that could potentially take place this year, Managing Director Hatem Hady tells Al Borsa. The list includes real estate developer Misr Italia, City Trade, and DBK Pharma.","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":633151,"url":"https:\/\/enterpriseam.com\/egypt\/2018\/02\/28\/saudis-marei-bin-mahfouz-group-acquires-25-in-dbk-pharma\/","url_meta":{"origin":645459,"position":4},"title":"Saudi\u2019s Marei bin Mahfouz Group acquires 25% in DBK Pharma","author":"enterpriseam admin","date":"28 February 2018","format":false,"excerpt":"M&A WATCH- Saudi Arabia\u2019s Marei bin Mahfouz Group has reportedly bought a 25% stake in DBK Pharma, signaling that the firm might have once and for all abandoned plans to relist on the EGX, according to Al Mal. The group acquired the shares for EGP 38.7 mn, and these were\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":639531,"url":"https:\/\/enterpriseam.com\/egypt\/2017\/10\/31\/efsa-sets-one-month-deadline-for-companies-to-ipo-after-receiving-approval\/","url_meta":{"origin":645459,"position":5},"title":"EFSA sets one month deadline for companies to IPO after receiving approval","author":"enterpriseam admin","date":"31 October 2017","format":false,"excerpt":"Companies will now have to IPO shares within one month of receiving approval to do so from the Egyptian Financial Supervisory Authority (EFSA), the authority said in a statement on Monday after amending listing regulations. Under new regulations, companies wishing to list new shares must first apply for approval from\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]}],"_links":{"self":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts\/645459","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/comments?post=645459"}],"version-history":[{"count":0,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts\/645459\/revisions"}],"acf:post":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/issue\/645451"}],"wp:attachment":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/media?parent=645459"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/categories?post=645459"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/tags?post=645459"},{"taxonomy":"brand","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/brand?post=645459"},{"taxonomy":"newspack_spnsrs_tax","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/newspack_spnsrs_tax?post=645459"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}